| glutamic-pyruvate transaminase | 
| Identifiers | 
| Symbol | GPT | 
| Entrez | 2875 | 
| HUGO | 4552 | 
| OMIM | 138200 | 
| RefSeq | NM_005309 | 
| UniProt | P24298 | 
| Other data | 
| EC number | 2.6.1.2 | 
| Locus | Chr. 8 q24.2-qter | 
| Alanine transaminase | 
| Identifiers | 
| EC number | 2.6.1.2 | 
| CAS number | 9000-86-6 | 
| Databases | 
| IntEnz | IntEnz view | 
| BRENDA | BRENDA entry | 
| ExPASy | NiceZyme view | 
| KEGG | KEGG entry | 
| MetaCyc | metabolic pathway | 
| PRIAM | profile | 
| PDB structures | RCSB PDB PDBe PDBsum | 
| Gene Ontology | AmiGO / EGO | 
| 
| Search |  
| PMC | articles |  
| PubMed | articles |  
| NCBI | proteins |  | 
Alanine transaminase (ALT) is a transaminase enzyme (EC 2.6.1.2). It is also called alanine aminotransferase (ALAT) and was formerly called serum glutamate-pyruvate transaminase (SGPT) or serum glutamic-pyruvic transaminase (SGPT). ALT is found in plasma and in various body tissues, but is most common in the liver. It catalyzes the two parts of the alanine cycle. Serum ALT level, serum AST (aspartate transaminase) level, and their ratio (AST/ALT ratio) are commonly measured clinically as biomarkers for liver health. The tests are part of blood panels.
Contents
- 1 Function
- 2 Clinical significance
- 3 See also
- 4 References
- 5 External links
 
Function
ALT catalyzes the transfer of an amino group from L-alanine to α-ketoglutarate, the products of this reversible transamination reaction being pyruvate and L-glutamate.
- L-glutamate + pyruvate ⇌ α-ketoglutarate + L-alanine
ALT (and all transaminases) require the coenzyme pyridoxal phosphate, which is converted into pyridoxamine in the first phase of the reaction, when an amino acid is converted into a keto acid.
Clinical significance
ALT is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health. When used in diagnostics, it is almost always measured in international units/liter (IU/L).[1][2] While sources vary on specific reference range values for patients, 10-40 IU/L is the standard reference range for experimental studies.[1] Alanine transaminase shows a marked diurnal variation.[citation needed]
The ratio of ALT to AST (aspartate transaminase) also has clinical significance.
Elevated levels
Test results should always be interpreted using the reference range from the laboratory that produced the result. However typical reference intervals for ALT are:
| Patient type | Reference ranges[3] | 
| Female | ≤ 34 IU/L | 
| Male | ≤ 52 IU/L | 
Significantly elevated levels of ALT (SGPT) often suggest the existence of other medical problems such as viral hepatitis, diabetes, congestive heart failure, liver damage, bile duct problems, infectious mononucleosis, or myopathy, so ALT is commonly used as a way of screening for liver problems. Elevated ALT may also be caused by dietary choline deficiency. However, elevated levels of ALT do not automatically mean that medical problems exist. Fluctuation of ALT levels is normal over the course of the day, and they can also increase in response to strenuous physical exercise.[4]
When elevated ALT levels are found in the blood, the possible underlying causes can be further narrowed down by measuring other enzymes. For example, elevated ALT levels due to hepatocyte damage can be distinguished from bile duct problems by measuring alkaline phosphatase. Also, myopathy-related elevations in ALT should be suspected when the aspartate transaminase (AST) is greater than ALT; the possibility of muscle disease causing elevations in liver tests can be further explored by measuring muscle enzymes, including creatine kinase. Many drugs may elevate ALT levels, including Zileuton, omega-3-acid ethyl esters (Lovaza),[5] anti-inflammatory drugs, antibiotics, cholesterol medications, some antipsychotics such as risperidone, and anticonvulsants.[citation needed]. Paracetamol may also elevate ALT levels.[6]
For years, the American Red Cross used ALT testing as part of the battery of tests to ensure the safety of its blood supply by deferring donors with elevated ALT levels. The intent was to identify donors potentially infected with hepatitis C because no specific test for that disease was available at the time. Prior to July 1992, widespread blood donation testing in the USA for hepatitis C was not carried out by major blood banks. With the introduction of second-generation ELISA antibody tests for hepatitis C, the Red Cross changed the ALT policy. As of July 2003[update], donors previously disqualified for elevated ALT levels and no other reason may be reinstated as donors by contacting the donor-counseling department of their regional Red Cross organization.[7]
See also
- Aspartate transaminase
- Liver function tests
References
- ^ a b Wang, CS; Chang, Ting-Tsung; Yao, Wei-Jen; Wang, Shan-Tair; Chou, Pesus (2012). "Impact of increasing alanine aminotransferase levels within normal range on incident diabetes". J Formos Med Assoc 111 (4): 201–8. doi:10.1016/j.jfma.2011.04.004. PMID 22526208. 
- ^ Ghouri, N; Preiss, David; Sattar, Naveed (2010). "Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data". Hepatology 52 (3): 1156–61. doi:10.1002/hep.23789. PMID 20658466. 
- ^ "Alanine aminotransferase: analyte monograph" (PDF). Association for Clinical Biochemistry and Laboratory Medicine. Retrieved 7 October 2013. 
- ^ Paul T. Giboney M.D., Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient, American Family Physician.
- ^ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683599/?tool=pmcentrez Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia, Pharmacy and Pherapeutics.
- ^ Watkins PB, Kaplowitz N, Slattery JT et al. (July 2006). "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial". JAMA: the Journal of the American Medical Association 296 (1): 87–93. doi:10.1001/jama.296.1.87. PMID 16820551. 
- ^ Red Cross Donor Requirements
 
External links
- Alanine transaminase at the US National Library of Medicine Medical Subject Headings (MeSH)
- ALT: analyte monograph; The Association for Clinical Biochemistry and Laboratory Medicine
- Alanine aminotransferase (ALT) at Lab Tests Online
| 
| Transferase: nitrogenous groups (EC 2.6) |  
|  |  
| 2.6.1: Transaminases | 
Aspartate transaminase
Alanine transaminaseGABA transaminaseTyrosine aminotransferaseOrnithine aminotransferaseBranched chain aminotransferaseAlanine—glyoxylate transaminase
 |  
|  |  
| 2.6.3: Oximinotransferases |  |  
|  |  
| 2.6.99: Other | 
Pyridoxine 5'-phosphate synthase |  
|  |  
| 
| 
| 
Biochemistry overviewEnzymes overviewBy EC number: 1.1
23456781011131415-182.1
3.1
4.1
5.1
6.1-3
 |  |  |  | 
| 
| Metabolism: carbohydrate metabolism: glycolysis/gluconeogenesis enzymes |  
|  |  
| Glycolysis | 
| 
Hexokinase (HK1, HK2, HK3, Glucokinase)→/Glucose 6-phosphatase←Glucose isomerasePhosphofructokinase 1 (Liver, Muscle, Platelet)→/Fructose 1,6-bisphosphatase← |  
|  |  
| 
Fructose-bisphosphate aldolase (Aldolase A, B, C)Triosephosphate isomerase |  
|  |  
| 
Glyceraldehyde 3-phosphate dehydrogenasePhosphoglycerate kinasePhosphoglycerate mutaseEnolasePyruvate kinase (PKLR, PKM2) |  |  
|  |  
| Gluconeogenesis only | 
| to oxaloacetate: | 
Pyruvate carboxylasePhosphoenolpyruvate carboxykinase |  
|  |  
| from lactate (Cori cycle): |  |  
|  |  
| from alanine (Alanine cycle): |  |  
|  |  
| from glycerol: | 
Glycerol kinaseGlycerol dehydrogenase |  |  
|  |  
| Regulatory | 
Fructose 6-P,2-kinase:fructose 2,6-bisphosphatase
PFKFB1, PFKFB2, PFKFB3, PFKFB4Bisphosphoglycerate mutase |  
|  |  
| 
| Index of inborn errors of metabolism |  
|  |  
| Description | 
MetabolismEnzymes and pathways: citric acid cycle
pentose phosphate
glycoproteins
glycosaminoglycans
phospholipid
cholesterol and steroid
sphingolipids
eicosanoids
amino acid
urea cycle
nucleotide
 |  
|  |  
| Disorders | 
Citric acid cycle and electron transport chainGlycoproteinProteoglycanFatty-acidPhospholipidCholesterol and steroidEicosanoidAmino acidPurine-pyrimidineHeme metabolismSymptoms and signs |  
|  |  
| Treatment |  |  
| Index of nutrition |  
|  |  
| Description | 
Vitamins
CofactorsMetal metabolismFats
metabolismintermediateslipoproteinsSugars
Glycolysis
Glycogenesis and glycogenolysis
Fructose and galactose
 |  
|  |  
| Disease | 
VitaminsCarbohydrateLipid
MetalsOtherSymptoms and signsTests |  
|  |  
| Treatment | 
Drugs
VitaminsMineral supplements |  |  | 
| 
| Metabolism: Protein metabolism, synthesis and catabolism enzymes |  
|  |  
| Essential amino acids are in Capitals |  
|  |  
| K→acetyl-CoA | 
| LYSINE→ | 
Saccharopine dehydrogenaseGlutaryl-CoA dehydrogenase |  
|  |  
| LEUCINE→ | 
Branched chain aminotransferaseBranched-chain alpha-keto acid dehydrogenase complexIsovaleryl coenzyme A dehydrogenaseMethylcrotonyl-CoA carboxylaseMethylglutaconyl-CoA hydratase3-hydroxy-3-methylglutaryl-CoA lyase |  
|  |  
| TRYPTOPHAN→ | 
Indoleamine 2,3-dioxygenase/Tryptophan 2,3-dioxygenaseArylformamidaseKynureninase3-hydroxyanthranilate oxidaseAminocarboxymuconate-semialdehyde decarboxylaseAminomuconate-semialdehyde dehydrogenase |  
|  |  
| PHENYLALANINE→tyrosine→ |  |  |  
|  |  
| G | 
| G→pyruvate →citrate
 | 
| glycine→serine→ | 
Serine hydroxymethyltransferaseSerine dehydratase 
glycine→creatine: Guanidinoacetate N-methyltransferaseCreatine kinase |  
|  |  
| alanine→ |  |  
|  |  
| cysteine→ |  |  
|  |  
| threonine→ | 
L-threonine dehydrogenase |  |  
|  |  
| G→glutamate→ α-ketoglutarate
 | 
| HISTIDINE→ | 
Histidine ammonia-lyaseUrocanate hydrataseFormiminotransferase cyclodeaminase |  
|  |  
| proline→ | 
Proline oxidasePyrroline-5-carboxylate reductase1-Pyrroline-5-carboxylate dehydrogenase/ALDH4A1PYCR1 |  
|  |  
| arginine→ | 
Ornithine aminotransferaseOrnithine decarboxylaseAgmatinase |  
|  |  
| →alpha-ketoglutarate→TCA |  |  
|  |  
| Other | 
cysteine+glutamate→glutathione: Gamma-glutamylcysteine synthetaseGlutathione synthetaseGamma-glutamyl transpeptidase 
glutamate→glutamine: Glutamine synthetaseGlutaminase |  |  
|  |  
| G→propionyl-CoA→ succinyl-CoA
 | 
| VALINE→ | 
Branched chain aminotransferaseBranched-chain alpha-keto acid dehydrogenase complexEnoyl-CoA hydratase3-hydroxyisobutyryl-CoA hydrolase3-hydroxyisobutyrate dehydrogenaseMethylmalonate semialdehyde dehydrogenase |  
|  |  
| ISOLEUCINE→ | 
Branched chain aminotransferaseBranched-chain alpha-keto acid dehydrogenase complex3-hydroxy-2-methylbutyryl-CoA dehydrogenase |  
|  |  
| METHIONINE→ | 
generation of homocysteine: Methionine adenosyltransferaseAdenosylhomocysteinase 
regeneration of methionine: Methionine synthase/Homocysteine methyltransferaseBetaine-homocysteine methyltransferase 
conversion to cysteine: Cystathionine beta synthaseCystathionine gamma-lyase |  
|  |  
| THREONINE→ |  |  
|  |  
| →succinyl-CoA→TCA | 
Propionyl-CoA carboxylaseMethylmalonyl CoA epimeraseMethylmalonyl-CoA mutase |  |  
|  |  
| G→fumarate | 
| PHENYLALANINE→tyrosine→ | 
Phenylalanine hydroxylaseTyrosine aminotransferase4-Hydroxyphenylpyruvate dioxygenaseHomogentisate 1,2-dioxygenaseFumarylacetoacetate hydrolase 
tyrosine→melanin: Tyrosinase |  |  
|  |  
| G→oxaloacetate | 
| asparagine→aspartate→ | 
Asparaginase/Asparagine synthetaseAspartate transaminase |  |  |  
|  |  
| 
| Index of inborn errors of metabolism |  
|  |  
| Description | 
MetabolismEnzymes and pathways: citric acid cycle
pentose phosphate
glycoproteins
glycosaminoglycans
phospholipid
cholesterol and steroid
sphingolipids
eicosanoids
amino acid
urea cycle
nucleotide
 |  
|  |  
| Disorders | 
Citric acid cycle and electron transport chainGlycoproteinProteoglycanFatty-acidPhospholipidCholesterol and steroidEicosanoidAmino acidPurine-pyrimidineHeme metabolismSymptoms and signs |  
|  |  
| Treatment |  |  |  | 
| 
| References ranges for blood tests (CPT 82000–84999) |  
|  |  
| Electrolytes | 
SodiumPotassiumChlorideCalciumRenal function
CreatinineUreaBUN-to-creatinine ratioPlasma osmolalitySerum osmolal gap |  
|  |  
| Acid-base | 
Anion gapArterial blood gasBase excessBicarbonateCO2 content |  
|  |  
| Iron tests | 
FerritinSerum ironTransferrin saturationTotal iron-binding capacityTransferrinTransferrin receptor |  
|  |  
| Hormones | 
ACTH stimulation testThyroid function tests
Thyroid-stimulating hormone |  
|  |  
| Metabolism |  |  
|  |  
| Cardiovascular | 
Cardiac marker
CPK-MB testLactate dehydrogenaseMyoglobinGlycogen phosphorylase isoenzyme BB |  
|  |  
| Liver function tests | 
Proteins
Human serum albuminSerum total proteinALPtransaminases
Bilirubin
 |  
|  |  
| Pancreas |  |  
|  |  
| 
| Index of the urinary system |  
|  |  
| Description | 
AnatomyPhysiologyDevelopmentCells |  
|  |  
| Disease | 
Electrolyte and acid-baseCongenitalNeoplasms and cancerOtherSymptoms and signsUrine tests
Blood tests |  
|  |  
| Treatment | 
ProceduresDrugs
Intravenous fluids |  
| Index of hormones |  
|  |  
| Description | 
GlandsHormones
thyroid
mineralocorticoidsPhysiologyDevelopment |  
|  |  
| Disease | 
DiabetesCongenitalNeoplasms and cancerOtherSymptoms and signs |  
|  |  
| Treatment | 
ProceduresDrugs
calcium balancecorticosteroidsoral hypoglycemicspituitary and hypothalamicthyroid |  
| Index of the heart |  
|  |  
| Description | 
AnatomyPhysiologyDevelopment |  
|  |  
| Disease | 
InjuryCongenitalNeoplasms and cancerOtherSymptoms and signs
Blood tests |  
|  |  
| Treatment | 
ProceduresDrugs
glycosidesother stimulantsantiarrhythmicsvasodilators |  
| Index of digestion |  
|  |  
| Description | 
Anatomy
Physiology
Development |  
|  |  
| Disease | 
CongenitalNeoplasms and cancerInflammatory bowel diseaseGluten sensitivityOtherSymptoms and signs
Blood tests |  
|  |  
| Treatment | 
ProceduresDrugs
anabolic steroidsantacidsdiarrhoea and infectionbile and liverfunctional gastrointestinal disorderslaxativespeptic ulcer and refluxnausea and vomitingotherSurgery |  |  |